Flavonoids
are known for potent antioxidant activity
and antihyperlipidemia.
As a result of the few antinutritional factors and high bioactive
substances, such as flavonoids, sprouts of tartary buckwheat (Fagopyrum tataricum, STB) have become healthy food.
This study aims to unravel the antihyperlipidemic effects of STB in vivo and its potential mechanism through transcriptomic
and metabonomic analysis. The physiological parameters of mice administered
the high-fat diet with or without 2.5 and 5% of STB for 10 weeks were
recorded. Liquid chromatography–tandem mass spectrometry and
RNA sequencing were applied to obtain the serum lipid metabolomic
and hepatic transcriptomic profiling, respectively. Results revealed
that STB could significantly alleviate the increase of body weight,
liver, and abdominal adipose while ameliorating the lipid content
in serum and insulin resistance of mice fed with a high-fat diet.
Notably, the metabonomic analysis identified the core differential
metabolites mainly enriched in the pathways, such as fat digestion
and absorption, insulin resistance, and other processes. Transcriptomic
results revealed that STB significantly altered the expression levels
of PIK3R1, LRP5, SLC10A2, and FBXO21. These genes are involved in the PI3K-AKT
signaling pathway, digestion and absorption of carbohydrates, and
type II diabetes mellitus pathways. In this study, STB exhibited remarkable
influence on the metabolism of lipids and glucose, exerting antihyperlipidemic
effects. STB have the potential for the development and application
of a lipid-lowering health food.